92 related articles for article (PubMed ID: 10442718)
1. A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology.
Flynn AA; Green AJ; Boxer G; Pedley RB; Begent RH
Phys Med Biol; 1999 Jul; 44(7):N151-9. PubMed ID: 10442718
[TBL] [Abstract][Full Text] [Related]
2. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
Kim JC; Roh SA; Koo KH; Ryu JH; Hong HK; Oh SJ; Ryu JS; Kim HJ; Bodmer WF
Int J Cancer; 2002 Feb; 97(4):542-7. PubMed ID: 11802220
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome.
Boxer G; Stuart-Smith S; Flynn A; Green A; Begent R
Br J Cancer; 1999 May; 80(5-6):922-6. PubMed ID: 10360677
[TBL] [Abstract][Full Text] [Related]
5. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY
Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
[TBL] [Abstract][Full Text] [Related]
6. Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images.
Flynn AA; Boxer GM; Begent RH; Pedley RB
Cancer Immunol Immunother; 2001 Apr; 50(2):77-81. PubMed ID: 11401028
[TBL] [Abstract][Full Text] [Related]
7. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
8. A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft model.
Flynn AA; Green AJ; Boxer GM; Casey JL; Pedley RB; Begent RH
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):183-9. PubMed ID: 9989525
[TBL] [Abstract][Full Text] [Related]
9. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments.
Obradovic V; Artiko V; Petrovic M; Stefanovic B; Krivokapic Z; Zuvela M; Stojkovic M; Stefanovic B; Milovanovic A; Vlajkovic M
Hepatogastroenterology; 2006; 53(70):526-30. PubMed ID: 16995454
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of radioimmunoguided surgery in colorectal cancer using 125I-labeled carcinoembryonic antigen-specific monoclonal antibody submucosally.
Gu J; Zhao J; Li Z; Yang Z; Zhang J; Gao Z; Wang Y; Xu G
Dis Colon Rectum; 2003 Dec; 46(12):1659-66. PubMed ID: 14668592
[TBL] [Abstract][Full Text] [Related]
12. Comparison of radioimmunodetection with other imaging methods in evaluating local relapses of colorectal carcinoma.
Gasparini M; Buraggi GL; Regalia E; Maffioli L; Balzarini L; Gennari L
Cancer; 1994 Feb; 73(3 Suppl):846-9. PubMed ID: 8306269
[TBL] [Abstract][Full Text] [Related]
13. Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.
Lee FT; Hall C; Rigopoulos A; Zweit J; Pathmaraj K; O'Keefe GJ; Smyth FE; Welt S; Old LJ; Scott AM
J Nucl Med; 2001 May; 42(5):764-9. PubMed ID: 11337573
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
[TBL] [Abstract][Full Text] [Related]
15. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody.
Mayer A; Tsiompanou E; O'Malley D; Boxer GM; Bhatia J; Flynn AA; Chester KA; Davidson BR; Lewis AA; Winslet MC; Dhillon AP; Hilson AJ; Begent RH
Clin Cancer Res; 2000 May; 6(5):1711-9. PubMed ID: 10815889
[TBL] [Abstract][Full Text] [Related]
18. Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma.
Kim JC; Kim WS; Ryu JS; Oh SJ; Lee DH; Koo KH; Roh SA; Kim HC; Yu CS; Kang GH; Bodmer WF
Cancer Res; 2000 Sep; 60(17):4825-9. PubMed ID: 10987293
[TBL] [Abstract][Full Text] [Related]
19. Genetically engineered antibody fragments and PET imaging: a new era of radioimmunodiagnosis.
Jain M; Batra SK
J Nucl Med; 2003 Dec; 44(12):1970-2. PubMed ID: 14660723
[No Abstract] [Full Text] [Related]
20. CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer.
Watanabe N; Oriuchi N; Endo K; Inoue T; Kuroki M; Matsuoka Y; Tanada S; Murata H; Kim EE; Sasaki Y
J Nucl Med; 2000 Feb; 41(2):337-44. PubMed ID: 10688120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
